Vinayak Doraiswamy
CIK: 0001862458
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AtriCure, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jul 28, 2026ATRC
AtriCure, Inc.
Sale(S)Direct6K shares at avg. $38.88$233K - Jun 30, 2026ATRC
AtriCure, Inc.
Award(A)Direct636 shares at avg. $23.78$15K - May 15, 2026ATRC
AtriCure, Inc.
Sale(S)Direct5K shares at avg. $28.13$141K - Mar 12, 2026ATRC
AtriCure, Inc.
Sale(S)Direct5K shares at avg. $29.83$149K - Mar 1, 2026ATRC
AtriCure, Inc.
Award(A)Direct15.2K shares- - Mar 1, 2026ATRC
AtriCure, Inc.
Award(A)Direct30.4K shares- - Mar 1, 2026ATRC
AtriCure, Inc.
Tax Payment(F)Direct15.6K shares at avg. $31.26$487K - Aug 5, 2025ATRC
AtriCure, Inc.
Sale(S)Direct2.5K shares at avg. $36.58$91K - Jun 30, 2025ATRC
AtriCure, Inc.
Award(A)Direct822 shares at avg. $25.84$21K - May 28, 2025ATRC
AtriCure, Inc.
Sale(S)Direct2.5K shares at avg. $33.44$84K - Mar 1, 2025ATRC
AtriCure, Inc.
Award(A)Direct19.4K shares- - Mar 1, 2025ATRC
AtriCure, Inc.
Award(A)Direct6.6K shares- - Mar 1, 2025ATRC
AtriCure, Inc.
Tax Payment(F)Direct9.7K shares at avg. $38.74$375K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 | ATRC AtriCure, Inc. | Sale(S) | 6,000 | $38.88 | $233,280 | Direct |
| Jun 30, 2026 | ATRC AtriCure, Inc. | Award(A) | 636 | $23.78 | $15,124 | Direct |
| May 15, 2026 | ATRC AtriCure, Inc. | Sale(S) | 5,000 | $28.13 | $140,650 | Direct |
| Mar 12, 2026 | ATRC AtriCure, Inc. | Sale(S) | 5,000 | $29.83 | $149,150 | Direct |
| Mar 1, 2026 | ATRC AtriCure, Inc. | Award(A) | 15,198 | - | $0 | Direct |
| Mar 1, 2026 | ATRC AtriCure, Inc. | Award(A) | 30,390 | - | $0 | Direct |
| Mar 1, 2026 | ATRC AtriCure, Inc. | Tax Payment(F) | 15,585 | $31.26 | $487,187 | Direct |
| Aug 5, 2025 | ATRC AtriCure, Inc. | Sale(S) | 2,500 | $36.58 | $91,450 | Direct |
| Jun 30, 2025 | ATRC AtriCure, Inc. | Award(A) | 822 | $25.84 | $21,240 | Direct |
| May 28, 2025 | ATRC AtriCure, Inc. | Sale(S) | 2,500 | $33.44 | $83,600 | Direct |
| Mar 1, 2025 | ATRC AtriCure, Inc. | Award(A) | 19,359 | - | - | Direct |
| Mar 1, 2025 | ATRC AtriCure, Inc. | Award(A) | 6,579 | - | - | Direct |
| Mar 1, 2025 | ATRC AtriCure, Inc. | Tax Payment(F) | 9,672 | $38.74 | $374,693 | Direct |
1-13 of 13 transactions
About Doraiswamy Vinayak
Doraiswamy Vinayak (SEC CIK 0001862458) files insider reports with the SEC as Chief Scientific Officer of AtriCure, Inc. (ATRC).
Signal8 holds 9 ownership filings by Doraiswamy Vinayak, all Form 4s, filed between Mar 4, 2025 and Jul 30, 2026. Those filings report 13 transactions, from Mar 1, 2025 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Doraiswamy Vinayak's filings is in MASON, OH.
Recent filings by Doraiswamy Vinayak
- Jul 28, 2026: Open-market sale of ATRC shares (Form 4, code S).
- Jun 30, 2026: Grant or award of ATRC shares (Form 4, code A).
- May 15, 2026: Open-market sale of ATRC shares (Form 4, code S).
- Mar 12, 2026: Open-market sale of ATRC shares (Form 4, code S).
- Mar 1, 2026: Grants or awards of ATRC shares (2 lines, Form 4, code A).
Other insiders filing for AtriCure, Inc. (ATRC)
- Privitera Salvatore, Chief Technical Officer
- GROVES REGINA E, Director
- Dahlquist Karl S., Chief Legal Officer
- Prange Karen, Director
- Yuen Maggie, Director
- CARREL MICHAEL H, President, CEO, & Director